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Abstract: Transcriptional enhancers are short (200–1500 
base pairs) DNA segments that are able to dramatically 
boost transcription from the promoter of a target gene. 
Originally discovered in simian virus 40 (SV40), a small 
DNA virus, transcription enhancers were soon also found 
in immunoglobulin genes and other cellular genes as 
key determinants of cell-type-specific gene expression. 
Enhancers can exert their effect over long distances of 
thousands, even hundreds of thousands of base pairs, 
either from upstream, downstream, or from within a tran-
scription unit. The number of enhancers in eukaryotic 
genomes correlates with the complexity of the organism; 
a typical mammalian gene is likely controlled by several 
enhancers to fine-tune its expression at different devel-
opmental stages, in different cell types and in response 
to different signaling cues. Here, I provide a personal 
account of how enhancers were discovered more than 
30 years ago, and also address the amazing development 
of the field since then.
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Prologue
Francis Crick once commented that after a new scientific 
concept is established, it is difficult – if not impossible – to 
see in the mind, how it was before. This applies perfectly 
to two phenomena that, in short succession, changed 
our understanding of eukaryotic gene regulation: introns 
and enhancers. They were not known in bacteria and no 
one had ever postulated their existence, simply because 
there seemed to be no need for them. Now that introns 
and enhancers are part of the scientific world, one cannot 
imagine how higher forms of life could ever have evolved 
without the multitude of tailored proteins that can be 
produced by alternative splicing, or without the sophisti-
cated patterns of remote transcription control by enhanc-
ers. Indeed, the complexity of an organism is primarily 
determined by the variety of gene regulation mechanisms, 
rather than by the number of genes.
The holy grail
In the fall of 1978, I returned to Zurich University from 
Cold Spring Harbor, following an offer from Max Birnstiel 
to establish my own group at the Institute of Molecular 
Biology II. At that time, the discovery of splicing introns 
had made its way into biology but enhancers were still to 
come. The elucidation of gene regulation in higher organ-
isms was then considered to be the holy grail of molecu-
lar biology, and it was also clear that this grail could only 
be reached by the use of genetic tests. But how? A few 
years earlier, the situation had been daunting. In bacterial 
and bacteriophage genetics, the key step was to cleverly 
interpret a plethora of random mutations. Compared to 
prokaryotes, generation times in the mouse, even in the 
fruit fly Drosophila, are discouragingly long, and thus the 
road to insight appeared endless. But the advent of DNA 
cloning in bacteria, together with the development of DNA 
sequencing in the mid 1970s, had changed everything. 
Suddenly, the genes of higher eukaryotes became open to 
experimentation. The irony of the new situation was that 
predetermined mutations, such as a deletion between 
two restriction cleavage sites, could be made with relative 
ease in a cloned gene, but it was not at all obvious how 
to test the outcome. The hope was to introduce a modi-
fied gene back into the nucleus, into the chromosomal 
DNA of a living cell, and assess the consequences. Zurich 
University was then a hotbed for this new research. Using 
newly available techniques, Max Birnstiel tested tRNA and 
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histone genes by injecting them into frog oocytes (Kress-
mann et al., 1978), and Charles Weissmann stably trans-
formed mouse fibroblasts with a β-globin gene that was 
linked to a selectable marker, a viral thymidine kinase 
(Mantei et al., 1979). Each of them created his own term 
for this new research endeavor: surrogate genetics (Max 
Birnstiel) and reverse genetics (Charles Weissmann). (For 
a personal account of early molecular biology in Zurich, 
see Schaffner, 1999.)
Eukaryotic gene regulation: nothing 
new?
How was gene activity regulated in higher organisms? 
Besides the classic bacterial operon with repressor and 
activator binding in the immediate vicinity of the tran-
scription start, alternative mechanisms also seemed pos-
sible. Britten and Davidson (1969), based on the surprising 
fact that many RNAs never leave the nucleus, proposed 
that classes of repetitive ‘activator RNAs’ would induce 
gene transcription by forming sequence-specific contacts 
to ‘receptor’ DNA associated with protein-coding genes. 
Adding to the mystery were the so-called lampbrush chro-
mosomes observed in oocytes of amphibians and certain 
insects, whereby all the chromosomes were thickly dec-
orated with their own transcripts. Were the messenger 
RNAs governing embryonic development processed from 
these long transcripts? In other words, was there perhaps 
no regulation of transcription whatsoever? (Curiously, 
what in our laboratory slang we called at the time the 
‘transcribe now, think later’ model, subsequently turned 
out to occur in some unicellular eukaryotes, including 
trypanosomes and Leishmania, where gene activity is reg-
ulated posttranscriptionally; Clayton, 2002).
When the dense fog that had shrouded the eukaryotes 
began to lift, the first glimpses seemed to confirm that 
gene regulation processes were similar to those of bacte-
ria. For example, Robert Tjian, ‘Tij’, a superb biochemist 
and lab mate during my Cold Spring Harbor time, found 
that T antigen, the major early protein of simian virus 40 
(SV40), bound to sites at the origin of replication which 
overlapped its own (‘early’) promoter region (Tjian, 1978; 
Rio et al., 1980). This suggested a function analogous to 
that of a bacterial repressor. Histone genes, unlike most 
other genes, occur in multiple copies per genome, which 
facilitated their isolation (Birnstiel et al., 1974). When the 
Hogness lab sequenced the Drosophila histone genes, 
upstream of their protein-coding regions a common 
AT-rich motif of consensus TATAAAT panned out; it was 
later referred to as the Hogness box, or TATA box (Lifton 
et al., 1978). The sequence of this motif, its defined position 
some 25 base pairs (bp) upstream of the transcription start 
(Gluzman et  al., 1980; Grosschedl and Birnstiel, 1980a) 
and its importance for proper transcription (Grosschedl 
et  al., 1981) were strikingly reminiscent of the bacterial 
TATAAT promoter motif, referred to as Pribnow box or -10 
box. It was also known that the eukaryotic 18S and 28S 
ribosomal RNAs were transcribed from one promoter as 
a long transcript, like a bacterial operon, and only later 
processed to individual RNAs (Dawid and Wellauer, 1976; 
Schibler et al., 1976). In this context it should also be noted 
that Ed Lewis in his classic analysis of the  Drosophila 
bithorax complex, described cis-acting mutations in puta-
tive repressor binding sites (Lewis, 1978).
Freshly-born PI: what to do?
I decided to study gene regulation in eukaryotes by 
combining my expertise in histone gene cloning and on 
simian virus 40 (SV40), stemming from the postdoc times 
at Zurich University and Cold Spring Harbor, respectively. 
SV40, a small DNA virus that readily grows in cultured 
monkey cell lines, was one of the most intensely studied 
viruses at that time. Like others in the field, I expected 
that eukaryotic gene regulation would likely mirror the 
situation in bacteria, though probably more complex with 
hundreds of repressors and corresponding binding sites 
in the promoters. I thus decided to start out by dissecting 
the putative regulatory elements upstream of the coding 
sequence of a histone gene, by doing what was later 
referred to as ‘promoter bashing’, i.e., introducing numer-
ous alterations and observing their effects. In retrospect 
this appears as a rather conventional project, but back 
then any kind of information on genes in a higher organ-
ism was exciting. There was the feeling of entering new 
land with the possibility of discovering something unex-
pected, and to ultimately find out how our own genes tick.
Advantage Berg
I intended to introduce cloned genes for functional tests 
into mammalian cells, using the calcium phosphate 
method that had hitherto been used for transfecting viral 
genomes or for stably transforming cells in culture. Recom-
binant DNAs were to consist of a vector plasmid, a eukary-
otic gene such as a sea urchin histone gene, and an SV40 
replicon. Only via viral DNA amplification, I reasoned, 
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could I hope to get sufficient gene copy numbers for expres-
sion analysis; because only a fraction of the cells in a Petri 
dish would be transfected, i.e., import the foreign DNA into 
the nucleus. On paper this was a great system: no tedious 
removal of the vector plasmid, no virus growth required, 
just DNA amplification and, most importantly, no size con-
straint for the gene to be tested. All these were advantages 
over the system of Paul Berg at Stanford who, in an attempt 
to use SV40 as a vector for gene therapy, had been able to 
produce β-globin protein in a recombinant virus by driving 
a globin cDNA minigene with the viral late promoter (Mul-
ligan et al., 1979). However, there was also a disadvantage 
of some relevance: his system worked, mine did not. In 
repeated attempts, all of my SV40-based recombinant plas-
mids stubbornly refused to replicate in monkey host cells, 
although there was adequate expression of T antigen, the 
viral replication factor. Was the large size of my constructs 
the problem? Were sea urchin histone genes incompatible 
with mammalian cells? Only one clone, a plasmid with 
three tandem inserts of the SV40 genome, worked – but 
alas, not as I expected: From the repeats, one complete viral 
genome popped out by recombination, replicated and pro-
duced virus, while the rest stayed behind, silent. This clone, 
pBSV3x, at least allowed me to turn the defeat into a small 
victory in another project (see below). Also it dawned on me 
that the vector plasmid was the culprit that was blocking 
replication, which of course destroyed the elegance of the 
system. Later I learned from Mike Botchan, a lab mate from 
the Cold Spring Harbor times and now at Berkeley, that 
they had independently found that SV40-type replication 
was blocked by ‘poisonous’ sequence elements in plasmid 
DNA (Lusky and Botchan, 1981; subsequently, I found that 
the inhibition was less pronounced with other types of 
plasmids and other cells; whether that insight would have 
accelerated, or rather delayed, enhancer discovery is diffi-
cult to say). Regardless, I found it disquieting that one year 
had gone by and I still had not gotten further with my main 
project, even though I was supported by a technician to 
help with routine work such as buffer and plasmid prepa-
rations. Like so many others, I had underestimated the time 
it takes to get a lab going smoothly. Fortunately, I enjoyed 
bench work tremendously, in line with the saying that a 
young group leader might still be his/her own best postdoc 
for years to come.
Spreading out in three directions
A tendency for tinkering and following up unexpected 
results was at the same time my strength and weakness. 
Indeed there was success on a side project: Out of curios-
ity I once tested whether recombinant plasmid DNA could 
be transferred directly from bacteria to mammalian cells, 
without the detour of plasmid isolation and purification. 
The above-mentioned pBSV3x plasmid came in handy for 
this, because even a single positive event in a culture dish 
would ultimately reveal itself due to the spread of a viral 
infection. Lo and behold it worked! Optimization of the 
technique followed, and the publication (Schaffner, 1980) 
gave me something to justify my existence. Because a 
given recipient cell could take up many identical plasmids 
from a single bacterium, this method was later adopted 
by a biotech company for the isolation of specific mam-
malian genes via expression selection.
When I realized that Max Birnstiel also intended to 
study the transcriptional regulation of his favorite histone 
genes, I resorted to another gene that I had unduly left 
waiting in the fridge for some time. During a visit to 
Caltech in spring 1978, I had met Tom Maniatis and asked, 
somewhat hesitantly, for a clone of the complete rabbit 
β-globin gene that, unlike a cDNA, would include all the 
regulatory promoter sequences. Red hot stuff – it was the 
first mammalian gene isolated! To my delight, Tom agreed 
instantly, generously provided DNA clones and all rel-
evant information without a request for co-authorship or 
other strings attached – and this even a few months before 
publication (Maniatis et al., 1978).
This change of test system came timely for ambi-
tious Sandro Rusconi, my very first PhD student, who 
was eager to generate transgenic frogs and mice (for 
 portraits of group members, see Figure 1). We reasoned 
that a hemoglobin component would be easier to detect 
and more likely to be tolerated by the host organism than 
a sea urchin protein – also the prospect of producing a 
mammalian protein was more attractive. For Sandro, 
obstacles of any size were a welcome challenge, and he 
soon got promising results by injecting the gene into fer-
tilized eggs of the clawed frog Xenopus laevis. The origin 
of this latter project seems worth mentioning, an illus-
tration of how in science (and elsewhere) one can miss a 
concept that in retrospect appears blatantly obvious. At 
that time I commuted by train and often conversed with 
passengers in the same compartment, sometimes prais-
ing enthusiastically the wonders of molecular research. 
Once I also mentioned DNA injection into frog oocytes, 
then the favored technique in the Birnstiel group (a 
living test tube, according to Max), and the response 
was: ‘And what happens later – are these frogs turning 
into part-sea urchins?’ Wow – yes – frogs that carry a 
foreign gene! How exciting! Strange as it sounds, up to 
then neither I nor the Birnstiel people had considered 
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following the fate of the injected genes through frog 
development, i.e., to produce transgenic animals.
A big effect, met with suspicion
To progress with my original project, the regulation of 
gene expression, I selected a line of HeLa cells that was 
easily transfectable, and also hoped that a newly obtained 
antibody for β-globin might be sensitive enough to reveal 
at least some globin expression in recipient cells. A 5000 
bp fragment of rabbit DNA harboring the β-globin gene 
was inserted via a unique KpnI cleavage site into two 
vector plasmids, one of which also contained an incom-
plete SV40 genome (Figure 2A,B). Why SV40, as it had 
not worked for amplification? Simply for convenience: I 
had a large batch of this plasmid, and the expression of 
T antigen would give a clue to the transfection efficiency. 
To my delight, when I tested both constructs in HeLa cells, 
β-globin was detectable by immunofluorescence – but 
only with the construct that contained SV40 DNA.
Skeptical, I assumed some kind of error in the inac-
tive recombinant – perhaps a globin mutation had inad-
vertently been generated upon sub-cloning? To test this, 
the globin gene was excised from that plasmid and cloned 
again into the SV40-containing vector (a legacy of my 
PhD training: don’t fool yourself, mind the controls). On 
January 15 1980, in the dark microscope room, it was clear: 
globin expression was indeed very strong, but only when 
the gene was linked to a segment of SV40 DNA! A strange 
but robust effect on gene expression was evident – and I 
was the lucky one to find it! My next thought, admittedly 
rather prosaic, was: ‘Great, this will keep me busy for a 
year!’ Because the construct did not replicate, an effect of 
gene copy number was excluded. The mind-blowing boost 
of globin expression brought about by the linked SV40 
DNA turned out to be highly reproducible, irrespective 
of the orientation of the globin insert at the KpnI cloning 
site, and with different constructs. Nevertheless, nagging 
doubts lingered for several months. Was it really genuine 
stimulation of globin transcription, as I assumed, or, far 
more trivial, just read-through from a viral promoter? (As 
the boosting effect was independent of globin gene orien-
tation, the latter seemed less likely). The possibility that 
the SV40 regulatory region encoded a short protein that 
stimulated globin mRNA translation was excluded by the 
finding that the viral DNA only worked in cis, i.e., not from 
a separate co-transfected molecule.
So far, all results were based on semi-quantitative 
immunofluorescence. Sandro Rusconi, who, as men-
tioned, was on his way to producing transgenic animals 
with the rabbit β-globin gene, diverted some time to 
my project and in summer 1980 did a crucial transcript 
mapping with S1 nuclease. He found that the active 
segment of SV40 DNA enhanced the level of transcripts 
from the genuine globin initiation site by at least 100-
fold! A spinoff technique from all this was the transient 
transfection assay. Its novelty deserved a publication of its 
own, which I failed to appreciate at the time.
Figure 1: The protagonists in the Zurich enhancer group of the early 1980’s. Top row from left to right: Sandro Rusconi, Julian Banerji, Laura 
Olson, Jean de Villiers. Bottom row from left to right: Frank Weber, Didier Picard, Walter Schaffner. (For their careers, see Acknowledgements.)
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Figure 2: The first viral and cellular enhancers.
(A) Schematic view of the non-coding control region of simian virus 40 (SV40) from which the first transcription enhancer (in green) was 
characterized (Banerji et al., 1981; Moreau et al., 1981). The early promoter region (in blue) contains three-fold repeated binding sites for 
the transcription factor Sp1 (Dynan and Tjian, 1983) and an AT-rich segment with a TATA box for binding of other transcription-relevant 
proteins. Even though enhancer and promoter elements may overlap, the activity of DNA-binding transcription factors can be specific; 
here, Sp1 preferentially activates transcription from a proximal (‘promoter’) position (Seipel et al., 1992). The duplication of the 72 base 
pairs (bp) segment, typical for the enhancer of SV40 laboratory strains, represents an adaptation to fast growth in tissue culture owing to 
increased early gene expression; the archetypical virus from macaques has only one 72 bp segment (Ilynskii et al., 1992). The duplication 
also illustrates a correlation between enhancer size and activity (Schaffner et al., 1988). (B) The recombinant plasmid (pBSVK+) that led to 
the discovery of the enhancer effect. It contained a β-globin transcription unit inserted at the KpnI cleavage site into an incomplete SV40 
genome. When this recombinant and a similar one lacking SV40 DNA were transfected side-by-side into human HeLa cells, β-globin expres-
sion was detectable by antibody-based immunofluorescence – but only in the construct with SV40 DNA. The same enhanced expression 
was observed with the twin plasmid pBSVK-, which contained the globin gene insert in opposite orientation, as indicated inside the circle. 
Subsequent quantification of globin mRNA revealed a 200-fold stimulation of globin transcripts by SV40 DNA (Banerji et al., 1981). (C) The 
first cellular, rather than viral, transcription enhancer (green) was identified in the immunoglobulin heavy chain (IgH) locus preceding the 
coding sequence for the constant part Cμ. Upon its activation the IgH enhancer, like many if not all enhancers, induces some local transcrip-
tion. Such transcripts, dubbed enhancer RNAs (eRNAs) (Kim et al., 2010; Andersson et al., 2014), can also include RNAs with a regulatory 
function (Orom and Shiekhattar, 2013). (D) After somatic IgH recombination, which links one of the V (variable) regions via a diversity (D) 
and a joining (J) element to Cμ, the enhancer is located in the intron between VDJ and Cμ and directs transcription of the IgH M chain mRNA 
(scheme below); (modified from Banerji et al., 1983).
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Taken together, these results meant nothing less 
than that the SV40 ‘enhancing’ DNA segment was able to 
boost transcription independent of its orientation and at 
distances of more than 1000 bp from a (related or unre-
lated) target promoter! And it even worked from a position 
downstream of the transcription unit. These properties 
were subsequently generally accepted as an enhancer 
definition.
At the 2nd International Congress on Cell Biology in 
Berlin in late summer 1980 I was scheduled for a talk in 
one of the parallel sessions and decided on short notice to 
report the enhancer effect. My presentation was met with 
apparently modest interest, underlined by some polite 
hand-clapping, a far cry from the bombshell I had dreamed 
of. Was the finding too alien to be accepted at once? Or 
was I simply too nervous to give a convincing presenta-
tion? Fortunately Phil Sharp, the co-discoverer of splicing, 
was part of the audience; he approached me afterwards, 
radiant, and called it ‘the discovery of the year’. ‘Thank 
you! but yours is the discovery of the decade’, I replied.
A bunch of characters
After showing that SV40-induced transcripts started at 
the correct globin 5′ end, Sandro returned to transgenics, 
while the SV40/globin project was continued by Julian 
Banerji, a new PhD student from Stony Brook. I had met 
him at Cold Spring Harbor where he impressed me as 
bright and curious, thus I offered him to come to Zurich. 
He was followed by his undergraduate girlfriend Laura 
Olson. As she was not yet eligible for a PhD program we 
employed her as a lab assistant and did not regret it – she 
turned out to be a reliable experimenter and great team 
member.
Julian was the only one who could design a complete 
cloning scheme of several steps without pen and paper, 
just in his head. Before others might have finished drawing 
a plan, he had already made the plasmid construct and 
variants of it, to be tested in a few blitz experiments. From 
the masses of data generated in intense bouts of activity, 
the correct results could be deduced. Julian was a great 
asset to the lab and basically a goodhearted fellow – but 
his critical attitude towards official authorities and blunt 
comments did not go down well with everybody. I myself 
was not a talented organizer, to say the least, but what-
ever I was and did, Julian did too, but more extremely. He 
would show up at noon or later but then, with an irregular 
mix of reading science, gossip, dedicated bench work and 
an occasional snack, easily stay till 6 am the following day.
And there were more PhD students knocking on my 
door: Jean de Villiers from South Africa and the ultra-
Swiss Frank Weber from the ETH nearby. Jean, who soon 
found in Julian a good buddy, was similarly outspoken, 
with comments on subprime scientific presentations such 
as ‘And the take-home message is: If you can’t convince 
them, confuse them.’ He was to be very productive, espe-
cially when considering that he also moonlighted as a male 
fashion model and was dating his newly-found Swedish 
girlfriend. Frank was an extremely skilled and efficient 
experimenter with a no-nonsense attitude – but a lost 
cause when it came to going for beers in a crammed bar. 
His clockwork 8-to-6 work discipline without any coffee 
breaks and time for chit-chat was met with a curious mix 
of playful derision and baffled admiration by Julian and 
Jean. At times I found it a challenge to integrate all these 
guys, each a primadonna in his own right, into a function-
ing team.
A new era
In the meantime Pierre Chambon (Strasbourg) who, like 
Max Birnstiel and Charles Weissmann, was a towering 
figure in Europe’s early molecular biology scene, was 
studying SV40 and ovalbumin genes. In autumn 1980 he 
co-organized a meeting at Seillac Castle, France. The pre-
vailing view at the time was that eukaryotic genes were 
controlled by promoters with a local influence, limited 
to about 100 bp from the initiation site, but this era was 
definitely to come to an end. At the castle, Max Birnstiel 
reported their studies on tRNA gene transcription and 
the finding of a ‘modulator’ DNA segment in the histone 
H2A gene of a sea urchin, located between -110 and -450 
bp from the transcription start. Deletion severely reduced 
transcriptional activity by more than one order of magni-
tude; surprisingly inversion of the segment, anticipated 
as a control, made it work even better! This was to be 
the first published case of a regulatory DNA sequence 
of a higher organism with activity in either orientation 
(Grosschedl and Birnstiel, 1980b). Pierre Chambon and 
Christophe Benoist reported that SV40 early gene tran-
scription depended on a segment between positions 
-100 and -260 that contained the so-called 72 bp repeats 
(Figure 2A)(Benoist and Chambon, 1981; see also Gruss 
et  al., 1981). I presented the SV40 enhancer effect, for 
the second time after the Cell Biology Congress in Berlin; 
this time it received more attention. In the coffee break 
Pierre and I discussed our findings, and we agreed that he 
would test activation at a distance, which obviously had 
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not occurred to him in their deletion studies, while we, 
having narrowed the activity to a segment with the SV40 
non-coding control region, were going to see whether his 
72 bp repeats contained the essence of enhancer activ-
ity. Julian Banerji was instrumental in consolidating and 
refining the story. He showed that the 72 bp repeats indeed 
represent a major part of the enhancer, also exploit-
ing some deletion mutants kindly provided by Yasha 
Gluzman (Cold Spring Harbor), who had produced them 
for other purposes. In one of Julian’s constructs, when the 
enhancer was flanked on both sides by plasmid DNA, the 
activity was severely reduced. This effect convinced us of 
the previously observed ‘activation from downstream’: in 
our circular recombinant DNAs (Figure 2B), an enhancer 
position downstream of the globin gene could also be con-
sidered to be far upstream of it; however, transmission in 
the latter case would have had to work through bacterial 
plasmid DNA, which was inhibitory.
I mailed a manuscript to Mike Botchan, to whom I owe 
most of what I will ever know about SV40. His response 
was enthusiastic: he had read the story ‘with bated 
breath’. ‘Why don’t we call your enhancer the Schaffner 
box’, he suggested. Although I was immensely flattered 
for a moment – after all a Hogness box, a Shine-Dalgarno 
sequence, a Pribnow box were already in circulation – I 
dismissed the idea (a case of thinking-outside-the-box, 
I assume) because it would have made light of the con-
tributions of Julian and Sandro. Instead, I used another 
term. Up to then I had referred to the enhancer effect, or to 
enhancer-active DNA; in his response Mike simply called 
it an enhancer, a term that I gladly adopted and that has 
stuck ever since.
Daring proposals
In parallel to the publication from Pierre Chambon and his 
colleagues (Moreau et  al., 1981) our long overdue paper 
appeared in Cell (Banerji et al., 1981). I was always eager 
to extract some biological sense from an observation. But 
from all the proposals made in our papers, those in our 
enhancer article were most grand and far-reaching. Yet, 
amazingly, they have stood the test of time:
An enhancer works in either orientation; it is able to 
activate a linked gene over long distances, even from a 
position downstream of the transcription unit. Enhancers 
are present in unrelated viruses such as retroviruses; viral 
oncogenesis can be the result of hyperactivation of a cellu-
lar regulator gene by the enhancer of a nearby inserted ret-
rovirus genome. In higher organisms, cellular enhancers 
are activating the genes within each chromosome domain, 
and classes of different enhancers are involved in the 
developmental, as well as the tissue-specific, expression 
of genes (Banerji et al., 1981).
Pierre Chambon and his formidable team – who often 
left their competitors behind in a cloud of dust – were less 
lucky in this case. Using two heterologous promoters and 
protein immunofluorescence as a readout, they also saw 
cases of an orientation-independent activation over a long 
distance. However, in a paradigmatic series of constructs 
with spacer inserts of different length, the effect faded out 
over about 700 bp, indicating that the enhancer segment 
was at its best when adjacent to, if not overlapping with, 
the promoter. A possible explanation for the discrepancy 
to our long distance effect is that they used plasmid frag-
ments as spacers – DNA which we had found to interfere 
with the transmission.
While the immunoglobulin enhancer would not have 
been found without Julian’s contribution (see below), the 
cornerstones of the SV40 enhancer story were already 
in place when he joined the team. So why was the first 
enhancer paper Banerji et al., rather than Rusconi et al.? 
Simple: for a daredevil and technical wizard like Sandro 
the enhancer effect was not enough. Son of a wine-maker 
in Ticino, the Italian-speaking part of Switzerland, tall 
and handsome, a skiing ace, admired by the students in 
lectures and lab courses; for him the sky was the limit. He 
wanted to be the first one to cure genetic diseases by gene 
therapy and to this end started out by genetically modify-
ing frogs and mice. Was he wrong to reach for the stars? 
It would be unfair to say that he grossly misjudged the 
importance of the enhancer effect. At that time, mind you, 
the SV40 enhancer could still have ended up as a peculiar 
trick of a small DNA virus. Sandro produced a fine PNAS 
paper on the generation of transgenic Xenopus (Rusconi 
and Schaffner, 1981) but with regard to transgenic mice 
he was seriously scooped by Frank Ruddle (Gordon et al., 
1980). In retrospect (as someone said, hindsight is an 
exact science) it would have been better for Sandro if he 
had stayed on to round off the enhancer story. Such are 
the vagaries of science, and life.
More enhancer properties emerge
How general was the enhancer effect? Jean de Villiers 
was quick to show that polyoma virus, a distant relative 
of SV40 in the mouse and founding member of the ever 
expanding family of polyomaviruses, also contained 
an enhancer next to the early promoter (de Villiers and 
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 Schaffner, 1981). Later, in a collaboration with Bob 
Kamen at ICRF London, he found that this enhancer also 
boosted viral DNA replication (de Villiers et  al., 1984). 
But what made an enhancer tick? Was it a specific DNA 
segment favorable for docking of RNA polymerase II, 
from where it would slide to the promoter? To our dis-
appointment, the few established or suspected enhanc-
ers known by then could not be aligned to a consensus 
sequence. Therefore, at one time we considered a pecu-
liar DNA structure for enhancers, rather than a primary 
sequence, but it became clear quite soon that the efforts 
to fold them into a unifying self-complementary struc-
ture were doomed.
A more complex scenario was suggested by new find-
ings from George Khoury’s and our lab, which indicated 
a species preference of enhancers. In mouse cells, the 
enhancers of a murine retrovirus and of mouse polyoma-
virus were highly active, while in monkey cells they were 
no match for the SV40 enhancer (de Villiers et al., 1982; 
Laimins et  al., 1982). The obvious explanation was that 
enhancers cooperated with cellular ‘factors’ such as pro-
teins. Later other labs, notably of Robert Tjian ( Berkeley), 
Albrecht Sippel (Freiburg) and Moshe Yaniv (Paris), pro-
vided evidence for proteins binding to promoters and/or 
enhancers using DNA footprinting, in vitro transcription 
and electrophoretic mobility shift assays (Dynan and 
Tjian, 1983; Nowock et al., 1985; Piette et al., 1985). Now it 
is clear that an enhancer is a DNA platform that interacts 
with a multitude of transcriptional regulatory proteins.
What a strange place to find 
an enhancer!
The big quest, however, was for a cellular enhancer. 
During this time Julian Banerji gained further momen-
tum, proposing new experiments every day, if not every 
hour. Not all were good, of course, and we anyway lacked 
manpower to pursue all his fancies. But once he made the 
brilliant suggestion that the best place to look for a cellu-
lar enhancer would be the immunoglobulin heavy chain 
(IgH) gene locus, on which he had done his master’s 
thesis at Stony Brook. The transcription rate at that locus 
was outrageously high, with RNA polymerases literally 
transcribing bumper-to-bumper. He constructed a series 
of plasmids with subsegments of the IgH locus, which 
I tested in HeLa and monkey CV-1 cells, alas without 
success. Our last hope was for an enhancer that would 
reveal itself only in B lymphocyte-type cells, the genuine 
antibody producer cells. At that time I did a major part 
of the lab’s cell culture work and considered myself an 
expert, but I repeatedly failed to transfect any B-type 
myeloma cells using the popular calcium phosphate 
method. Even the selection of a variant line of these cells 
that I got to flatten and attach weakly to the culture dish, 
was to no avail.
Almost one year later I resorted to DEAE dextran, an 
old and comparably inefficient transfection method, as 
well as gentler cell fixation. This was the breakthrough; 
B cells gave a strong signal with the SV40 enhancer and, 
amazingly, also with one of the segments from the IgH 
gene! With initial disbelief Julian and I checked again and 
again the position of the active segment: unlike SV40, 
where the enhancer was relatively close to the initiation 
site, if not interwoven with the promoter, the IgH enhancer 
was located within the intron preceding the constant 
region, which meant that it activated the promoter from 
within the transcription unit and only after a productive 
Ig gene rearrangement (Figure 2C,D). Most importantly, it 
also meant the immunoglobulin enhancer was cell-type-
specific – the first genetic element of its kind! And of 
course it demonstrated that a downstream enhancer posi-
tion was a reality and did not only work in synthetic glo-
bin-SV40 constructs. What was more, the enhancer could 
explain why chromosome translocations that brought a 
c-myc gene into the vicinity of the IgH locus were often 
observed in leukemia. The latter was an insightful sugges-
tion by Julian – irrespective of the fact that later studies in 
Michael Neuberger’s lab revealed another strong enhancer 
downstream of the IgH locus as the major culprit in myc 
deregulation (Pettersson et al., 1990).
Here was one of the very few moments in my life 
where an experimental result that was at first confusing, 
in one stroke provided an elegant explanation for several 
phenomena.
Feeling the breath of competitors
When I presented the cell-type-specific IgH enhancer at 
a Cold Spring Harbor Workshop on Enhancers in spring 
1983, I learned to my dismay that Susumu Tonegawa had 
obtained essentially the same results. After my return 
to Zürich I got a phone call from Ben Lewin of Cell who 
invited me to publish our findings in his journal, only to 
get another call shortly thereafter from Peter Newmark, 
Editor of Nature, with the same offer. Not only had the 
rumor spread from the Cold Spring Harbor Meeting, I also 
learned that Susumu had already been bargaining with 
both Cell and Nature for quickest possible publication.
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After Peter Newmark’s call I rushed from my small 
office, shouting, ‘Hey, everybody listen, would you 
believe it! CELL and NATURE want our immunoglobulin 
enhancer paper! They both called me and ASKED for it! 
This is MOUNT EVEREST! We’re SUPERSTARS!’ There was 
excited yelling, mutual shoulder-patting and, admittedly, 
a good portion of naive hubris. It didn’t last for long. My 
wife Marianne, always providing loving support especially 
in tough times, is good at keeping my feet on the ground 
in moments of over-inflated self-confidence: ‘Giants, you 
guys? Isn’t this like giant prawns where even the biggest 
ones are not all that big?’
Remembering that Ben Lewin had given a fair treat-
ment to our first enhancer paper (that had come, mind 
you, from a relatively unknown junior group), I stayed 
with Cell, and so in the end did Tonegawa (Banerji et al., 
1983; Gillies et  al., 1983). David Baltimore and Michael 
Neuberger also published on immunoglobulin enhancers, 
but their data were less complete (Queen and Baltimore, 
1983) or appeared substantially later (Neuberger, 1983). 
Didier Picard, an undergraduate and graduate student in 
my lab, later found upstream sequences of the Ig lambda 
gene to inhibit transmission of the enhancer effect, and 
characterized the Ig kappa enhancer (Picard and Schaff-
ner, 1983, 1984). He impressed me so much with an 
essentially perfect draft of his very first publication that I 
hesitated to put my name on it.
The enhancer trap, a Hershey 
heaven
In parallel to the IgH efforts, we developed an ‘enhancer 
trap’. It consisted of an enhancer-less, linearized SV40 
genome that was unable to grow in transfected monkey 
cells unless it picked up one that had enhancer activity 
from a mix of sonicated, co-transfected DNA fragments. 
Our assumption – quite daring – was that the host cell 
would do it all: namely, trim the transfected fragments, 
fuse them to the ends of SV40 to produce circular DNAs 
and then allow the right one to multiply. When it worked it 
was praised as an elegant technique, but at the time it was 
uncertain whether it would ever succeed. Julian and Chris-
toph Gehring, a short-term postdoc, did the initial construct 
and gave it a first try, Jean continued, but to have ends meet 
(literally!) the project needed Frank. He delivered – on time 
(Weber et al., 1984). A follow-up collaboration with the lab 
of Bernhard Fleckenstein (Erlangen) led to the isolation 
of the very strong, ubiquitously active cytomegalovirus 
enhancer, which is now widely used by biotech companies 
for protein production in mammalian cells (Boshart et al., 
1985). Incidentally, a completely different enhancer trap 
system was developed in Drosophila by Walter Gehring and 
colleagues in Basel (Bellen et al., 1989).
Using our enhancer trap, we isolated one enhancer 
after another. It was ‘Hershey heaven’! [For one of the 
founders of molecular biology, Al Hershey, heaven was ‘To 
have one experiment that works, and keep doing it all the 
time’ or, in a more wordy version, to come to the lab every 
morning, to perform a significant experiment, and to find 
out that it worked (Stahl, 2000)]. Regarding publications 
we had a good harvest with enhancers from different virus 
classes, but hardly from cellular genes. A nice example 
of the latter was the incorporation of upstream segments 
of either human or mouse metal-inducible metallothio-
nein genes – the resulting SV40 recombinants could only 
grow in host cells whose medium was supplemented with 
zinc (Serfling et al., 1985). The downside of this string of 
success was that I missed the first train to enhancer-bind-
ing proteins.
Clairvoyants and potential 
discoverers
Considering our talkative attitude and meandering 
working habits, it was sheer luck that we did not get 
scooped on the enhancers; nor were we seriously chal-
lenged for priority after publication. Amusing, rather than 
annoying, were the few wise men, typically outing them-
selves at the bar after a conference’s evening session, for 
whom the enhancer effect was either ‘logical’, ‘obvious’, 
or who had ‘foreseen it’ (without leaving a record) or, even 
better, ‘would have predicted it’.
Would the enhancer effect have been discovered 
anyway? Certainly! The story was bound to unfold, but 
most likely in smaller bits, step by step, rather than in one 
fell swoop. Harbingers included the mentioned studies 
in Pierre Chambon’s and George Khoury’s lab on the 72 
bp repeats of SV40 (Benoist and Chambon, 1981; Gruss 
et  al., 1981) as well as the bipolar ‘modulator’ DNA of 
Max Birnstiel and his super-PhD student Rudi Grosschedl 
(Grosschedl and Birnstiel, 1980b; see also Grosschedl and 
Birnstiel, 1982; Grosschedl et al., 1983). A later investiga-
tion in Giovanni Spinelli’s lab identified typical enhancer 
properties in a subsegment of this modulator (Palla et al., 
1994). Coming from a totally different angle, Mario Capec-
chi observed in cell transformation experiments a greatly 
increased number of colonies positive for thymidine 
kinase (TK) if the input DNA harbored, besides a viral TK 
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gene, also the SV40 origin of replication region. However, 
in an extrachromosomal state, TK expression was high 
even without SV40 DNA, strongly suggesting that the 
role of SV40 was to facilitate integration into the recipi-
ent cell’s genome (Capecchi, 1980). On a similar track but 
using cellular DNA, Mike Botchan and Sue Conrad identi-
fied in the human genome multiple sequences with simi-
larity to the SV40 origin region. When one of these was 
linked to a TK gene, it boosted TK expression in stably 
transformed cells (Conrad and Botchan, 1982).
A gene’s major enhancer activity can be relatively 
close to the promoter region or even overlap with it, as in 
SV40 and some other viruses, the histone H2A, or metal-
lothionein genes (but not the β-globin or immunoglobu-
lin loci, see above). Given the still-strong influence of the 
bacterial promoter concept at that time, it is difficult to 
say how long it would have taken any of these other labs 
to realize that an enhancer-active segment could induce 
correct transcripts, also in an unrelated gene, independ-
ent of orientation and chromosomal integration, over 
long distances and even from a position downstream of 
the transcription unit.
Why activation over long distances?
With the publications on cellular enhancers in 1983 it 
became clear that enhancers were here to stay. And how 
they stayed! There were times when the human genome 
was thought to consist of 100,000 genes. While the gene 
number meanwhile has shrunk to about 25,000, the 
number of enhancers has gone on and on increasing, and 
often a given transcription unit is controlled by several 
enhancers. A classic study by Markus Noll and Werner 
Boll revealed a plethora of enhancers with different spe-
cificities, all of them associated with a single developmen-
tal regulator gene, the Drosophila Pox neuro locus (Boll 
and Noll, 2002). Nowadays, huge numbers of enhanc-
ers can be functionally identified with high-throughput 
techniques; a particularly ingenious one was developed 
by Alex Stark and colleagues (Arnold et  al., 2013). The 
current estimate for mammals, mostly based on an analy-
sis of enhancer-typical histone modifications, puts the 
number of enhancers at more than 300,000, perhaps as 
high as 1 million (ENCODE Project Consortium, 2012). And 
the maximal distance of activation was pushed farther 
and farther – some enhancers are located 1 million base 
pairs from the target promoter (for reviews, see Arnosti 
and Kulkarni, 2005; Visel et al., 2009; Levine, 2010; Bulger 
and Groudine, 2011; Spitz and Furlong, 2012; Levine et al., 
2014; Morange, 2014; Shlyueva et al., 2014). Mammalian 
chromosomal domains span long DNA segments in the 
range of one megabase and enhancer-promoter interac-
tions are usually confined to the same domain. Neverthe-
less – how can transcription be activated over distances 
of thousands, even hundreds of thousands of base pairs? 
It was already suspected early on that enhancers and pro-
moters communicate by physical interaction, whereby the 
intervening DNA is looped out (Figure 3). Evidence sup-
porting such a scenario has steadily increased (Müeller-
Storm et al., 1989; Su et al., 1991; Martin et al., 1996). In 
many cases, enhancer-promoter contacts are stabilized 
by cohesins, proteins that also play a role in chromosome 
pairing. How does each enhancer find its target? Proximity 
to one vs. anther promoter helps, but there are numerous 
exceptions, and open questions remain in spite of recent 
progress such as the finding that Drosophila ‘housekeep-
ing’ genes specifically interact with an enhancer class 
of their own (Zabidi et  al., 2014). One also may wonder, 
why remote control? Wouldn’t it be simpler to have all the 
DNA elements for transcription control close to the tran-
scription start? This is indeed the rule in simple eukary-
otes such as yeast, and even in the fruit fly Drosophila, 
enhancers are less numerous (50,000–100,000) and less 
widely dispersed than in mammals (Kvon et al., 2014; in 
this latter study, the estimate was based on functional 
tests). I suspect that on the one hand, the selection pres-
sure for economizing on genome size in short-generation-
time organisms may contribute to this difference; on the 
other hand, many mammalian genes are expected to be 
controlled by tens of enhancers and it might be too dif-
ficult to pack all of them into a contiguous DNA stretch 
without them interfering with each other.
Enhanceosomes and the activation 
from close-by
Having worked for many years on sea urchin histone 
genes, SV40, and heavy metal-responsive genes I couldn’t 
fail to notice that there are genes with strong enhancer 
activity close to, or even overlapping with, the promoter 
region, including the aforementioned genes for met-
allothioneins, histones of early cleavage stages, viral 
proteins in SV40 and also other viruses such as cytomeg-
alovirus and retroviruses, heat shock proteins, and the 
anti-viral interferons. For the latter ones, the upstream 
enhancer region was described as a well-structured entity 
(‘enhanceosome’) with specific activating factors and 
‘architectural’ proteins (Thanos and Maniatis, 1996). A 
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Figure 3: Activation of an enhancer.
(A) Schematic view of an inactive enhancer that is packaged into chromatin and poorly accessible for DNA-binding transcription factors. 
Histones in these nucleosomes carry posttranslational modifications characteristic for inactive, ‘closed’ chromatin (not indicated here). (B) 
Chromatin may be opened by a ‘pioneer factor’, a DNA binding transcription protein that is able to nevertheless occupy its binding site and 
will attract chromatin remodeling proteins and histone modifying enzymes. (As an alternative to a pioneer factor, a sufficient concentra-
tion of several DNA-binding transcription factors can cooperatively occupy an enhancer.) (C) Depletion of nucleosomes and introduction of 
enhancer-typical histone modifications in the neighborhood (H3K4me1, H3K27ac) render the enhancer accessible to further DNA-binding 
transcription factors (and cofactors such as the mediator complex, see below) as a prerequisite for its activity. The pioneer factor at this 
stage might even become dispensable/replaced by another transcription factor. (D) Scheme of enhancer-promoter interaction via DNA 
looping. The concerted action of enhancer-binding and promoter-binding proteins including a set of general transcription factors (GTFs), 
coactivators such as p300 (which has histone acetylase activity), the mediator multiprotein complex and cohesin (which can stabilize 
enhancer-promoter interaction), enables RNA polymerase II to initiate transcription. A promoter-typical histone modification (H3K4me3) is 
also indicated; see also recent reviews (Levine, 2010; Bulger and Groudine, 2011; Zaret and Carroll, 2011; Spitz and Furlong, 2012; Calo and 
Wysocka, 2013; Grünberg and Hahn, 2013; Levine et al., 2014; Shlyueva et al., 2014). Observations of transcriptional ‘bursts’ and intermit-
tent periods of inactivity (with the ‘off’ intervals becoming shorter upon higher transcription activity) may be the result of on-off enhancer-
promoter contacts and/or other forms of dynamic interactions (Amano et al., 2009; Suter et al., 2011).
common denominator of most of these genes is that they 
have to quickly jump into action, which might be more 
difficult with a remote enhancer, be it that looping takes 
more time, or that loops are less stable especially under 
stress. Under such conditions, splicing might also become 
a burden; metallothionein genes have short introns only, 
and genes for type I interferons, for a class of histones, and 
for the major heat shock proteins lack introns altogether.
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Epigenetic marks, redundancy of 
function, synthetic enhancers
Typical cellular enhancers are several hundred bp long 
and represent an array of binding sites (6–12 bp each) for 
a multitude of DNA-binding transcription factors. Single, 
isolated binding sites out in genomic no-man’s-land are 
usually unavailable for factor binding, because of the 
packaging of DNA into nucleosomes; only when sites are 
clustered do transcription factors have a chance to bind 
and prevail over nucleosomes, whereby a ‘pioneer factor’ 
might pave the way for others (Figure 3). The active state 
of enhancers is reinforced by ‘active’, or ‘open’ chromatin 
where nucleosomal histone proteins are specifically modi-
fied, notably by monomethylation of lysine 4 and acety-
lation of lysine 27 in histone H3 (H3K4me1 and H3K27ac, 
respectively). The acetylases and methylases responsi-
ble for these epigenetic modifications are brought to the 
enhancer region via direct or indirect binding to DNA-
bound transcription factors. ‘Open’ chromatin is particu-
larly sensitive to DNase treatment, a property that has long 
been exploited in the search for candidate enhancers.
Classical genetics dealt with the terms ‘necessary but 
not sufficient’ or ‘necessary and sufficient’. For example, 
deletion of a protein-coding segment that results in loss 
of gene activity shows that the segment is necessary; 
however, to restore the function in a mutant organism, a 
complete gene has to be provided (necessary and suffi-
cient). A surprising and seemingly paradoxical property of 
enhancers is that many of them are ‘sufficient but not nec-
essary’. For example, a virus with only half of its enhancer 
might still grow in cell culture (Schaffner et  al., 1988); 
however, in a direct competition the wild type virus would 
win. Mike Levine and colleagues noted that in Drosophila, 
some regulators of development are under the control of 
two enhancers, whereby one of them was dubbed shadow 
enhancer. Each one of these enhancers can induce the 
same or a similar pattern of gene expression, but under 
stressful conditions such as elevated temperature, both 
enhancers are needed to ensure robust regulation (Perry 
et al., 2010). Thus what appears at first sight as a luxuri-
ous redundancy, upon closer investigation reveals itself 
as a feature of increased fitness under adverse conditions.
As the building blocks of enhancer activity are short DNA 
sequence motifs, synthetic, highly active enhancers can be 
constructed that consist of multiple binding sites for just one 
type of transcription factor (Gerster et al., 1987; Ondek et al., 
1987; Schatt et al., 1988). Such monotonous enhancers do not 
occur in nature because they would not be compatible with 
a sophisticated regulation by different transcription factors 
and signaling pathways. Nevertheless, synthetic enhancers 
are useful when only one specific function is required: for 
example, multiple copies of binding sites for the transcrip-
tion factor Gal4 are widely used for controlled transgene 
expression in Drosophila (Brand and Perrimon, 1993).
Of small enhancers and 
super-enhancers
Most viral genomes are subject to a strong size constraint 
and thus are more densely packed with genetic informa-
tion than the typical chromosomes of eukaryotic cells. It 
is therefore to be expected that viruses also economize 
on the size of their transcription enhancers. Indeed the 
very small hepatitis B virus (genome size 3.2 kb) harbors 
an enhancer of some 170 bp that is even contained 
within the coding sequence for viral polymerase – quite 
a feat considering that two independent functions have 
to be preserved: enhancer activity and protein activity 
(Tognoni et  al., 1985). In the somewhat larger polyoma-
viruses (genome of 5.2 kb), the enhancer is part of the 
non-coding control region and appears to be suboptimal 
for efficient transcription. When such ‘archetype’ viruses 
are adapted to cell culture or otherwise freed from the 
threat of the host’s immune defense, variants appear that 
have undergone rearrangements in the enhancer, result-
ing in stronger early gene expression and more rapid 
virus growth (see also Figure 2A). The BK polyomavirus 
(BKPyV) is a paradigm of this phenomenon. BKPyV is 
widely distributed in human populations (prevalence 
about 80%) and typically persists as a commensal, symp-
tomless virus. However, in immunocompromised indi-
viduals, virus variants of increased growth efficiency and 
pathogenicity often emerge. Their analysis reveals mul-
tiple rearrangements of the enhancer, typically duplica-
tions of some and deletions of other parts (Moens et al., 
1995; Gosert et al., 2008); the most likely explanation is 
that the BKPyV archetypal enhancer has evolved to keep 
viral gene expression under careful control, such that the 
virus replicates just enough to be maintained within the 
host but remains ‘under the radar’ of the immune system. 
The longest, and also strongest, viral enhancers are found 
in cytomegaloviruses, large members of the herpesvirus 
family (Boshart et al., 1985; Dorsch-Häsler et al., 1985).
Rick Young and colleagues have noted that genes 
coding for master regulators of cell identity tend to be asso-
ciated with ‘super-enhancers’, extended DNA segments 
that harbor several enhancers. Of the many enhancers that 
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are active in a given cell, a minor subset is clustered into 
such super-enhancers (Whyte et al., 2013). The latter were 
defined by their large size, in the order of 20 kb; a high rep-
resentation of binding sites for key regulators, such as the 
PU.1 transcription factor in B lymphocyte precursor cells; 
clusters of DNase I hypersensitivity sites; the enhancer-
typical histone modifications, and an overrepresentation 
of bound ‘mediator’, a coactivator complex that facili-
tates recruitment of RNA polymerase II to the promoter. 
Extended enhancer regions that would qualify as super-
enhancers were also identified by others. In addition to 
examples in Drosophila such as the mentioned Pox neuro 
locus (Boll and Noll, 2002), Frank Grosveld and colleagues 
found a ‘locus control region’ (LCR), a cluster of remote 
enhancers that regulates expression of the different β-type 
globin units (Grosveld et al., 1987; Talbot et al., 1989) and de 
Laat and Duboule (2013) described a ‘global control region’ 
(GCR) of multiple enhancers that regulates hand and digit 
formation by the HoxD gene cluster. In cancer cells, genes 
for oncogenic drivers such as c-Myc are also associated with 
super-enhancers (Loven et al., 2013). Generally, genes with 
super-enhancers are strongly expressed but have an ‘Achil-
les heel’: they are particularly sensitive to a reduction of the 
mediator complex and of BRD4, a bromodomain coactiva-
tor. Accordingly, therapeutic reduction of BRD4 and media-
tor appears to be a promising venue for anticancer therapy 
(Loven et al., 2013 and references therein).
Epilogue
Since 1981, a discovery made in a small DNA virus 
has developed into a universe of transcriptional gene 
regulation, advanced primarily by experiments in insects 
and mammals. Enhancers, in concert with other cis-active 
elements such as promoters, silencers (Brand et al., 1985) 
and boundary elements/insulators (Kellum and Schedl, 
1991) (Figure 4), play a central role in normal and patho-
logical processes – consistent with the notion that the 
majority of disease-associated human single-nucleotide-
polymorphisms (SNPs) are located in the non-coding 
part of the genome (Rada-Iglesias, 2014). Enhancers can 
even be responsible for curious effects such as determin-
ing the blond hair color of northern Europeans (Guenther 
et al., 2014). Undoubtedly we know a lot – but how much 
don’t we know? Even after more than three decades of 
study, important aspects of enhancer biology remain to 
be clarified, including the exact sequence requirements, 
the precise roles of the different transcription factors and 
cofactors, and the wiring of enhancers to their correct 
target promoters. Why did we not harvest a plethora of 
cellular enhancers in our SV40 trap experiments – is a 
typical enhancer not compact and active enough to fit into 
a space-constrained viral genome? As enhancers contrib-
ute to viral host range, could this reflect a passive defense 
mechanism of the organism to avoid enhancers being cap-
tured by viruses? Apart from all this I find it a mystery how 
a cell, especially a mammalian cell, manages to coordinate 
its countless enhancers, DNA loops, transcription factors 
and regulatory RNAs, not least because most of them may 
be expected to also produce some undesired off-target 
effects. What is more, we know little about how genes and 
especially their regulatory elements have governed the 
evolution from one type of body plan to another, with all 
the necessary physiological adaptations. Even with access 
to the complete genomes of several mammals, birds and 
reptiles, the maps of all enhancers, and tissue-specific 
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Figure 4: Landscape of cis-acting DNA regulatory sequences.
Depending on the cell type and signaling state, the promoter (P) of a transcription unit may be activated by one or the other enhancer, or 
kept in a repressed state by a silencer (Brand et al., 1985). Other enhancers or silencers (right-hand side) cannot influence activity, due 
to the shielding effect of insulator/boundary elements (Kellum and Schedl, 1991). Note that both Figures 3 and 4 represent simplified 
schemes. Depending on the cell type and the specific gene, both the DNA binding transcription factors and the composition of the multipro-
tein coactivator complexes can vary. Furthermore, insulators can bracket more than one transcription unit and multiple enhancers, and an 
enhancer may skip a proximal transcription unit to activate a more distal one. Additionally, enhancers and silencers are not always physi-
cally separated; binding of repressing factors or co-factors to an enhancer region can prevent its untimely activation. Enhancers typically 
work in cis, i.e., on the same DNA molecule as shown here, but in some cases, notably in the paired chromosomes of Drosophila, they can 
also act on the corresponding gene of the homologous chromosome. The latter phenomenon called transvection (Judd, 1988).
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protein expression patterns, we would be at a complete 
loss to design a perfectly viable, close mimic of a dinosaur. 
(Or, to name a truly grand vision: a dog that closes the 
windows when a thunderstorm is approaching, instead of 
hiding under the sofa.)
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Massachusetts General Hospital); Laura Olson (became 
Julian’s wife, an MD, a loving mother of two and works 
as a general practician); Jean de Villiers (was a postdoc 
with Bob Kamen at the Genetics Institute, group leader at 
a startup biotech company, now owns Chole Mjini Lodge, 
an amazing Tree House Hotel that he built himself on a 
small island in a marine park off the coast of Tanzania); 
Frank Weber (went directly to Roche Co. as head of an 
R&D lab and is now in a leading position at Johnson & 
Johnson Co.); Didier Picard (also did a postdoc with Keith 
Yamamoto and returned to Switzerland as a Professor in 
Geneva); and all the students and postdocs who followed 
them. I feel lucky that, besides all other circumstances, I 
had great mentors: my teacher Max Oettli encouraged me 
to study biology; I got excited about genetics with Ernst 
Hadorn; had the best possible training in molecular biol-
ogy during my PhD with Charles Weissmann; and at Cold 
Spring Harbor Lab learned how to handle viruses from 
Michael Botchan, the late Yasha Gluzman, Bill Topp, Ash-
ley Dunn, Robert Tjian, and Joe Sambrook. In retrospect 
I am simply amazed how well enhancers were received 
by the latter colleagues who, from their interests, might 
also have been classed as competitors. Even one of our 
strongest competitors, Pierre Chambon, was always fair 
in giving us credit. I am particularly grateful to Max L. 
Birnstiel who hired me to the position of a senior post-
doc right after the completion of my PhD, organized my 
memorable stay in the lab of Fred Sanger to learn DNA 
sequencing, offered me an independent Assistant Pro-
fessorship to return from Cold Spring Harbor (and I 
mean really independent, which was not the norm back 
then), endorsed a free exchange of results between our 
groups, tolerated my sometimes loose mouth and the 
unruly bunch of my early PhD students, and later was my 
loyal supporter free of envy when our viral and cellular 
enhancers made the headlines. Sadly Max passed away 
last year at age 81. This article is thus dedicated to an out-
standing scientist and a great mentor to all those who had 
the privilege to work with him.
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